ABSTRACT BACKGROUND Optimal patient characterization in heart failure with preserved ejection fraction (HFpEF) is essential to
H eart failure with preserved ejection fraction (HFpEF) is an increasingly common condition accounting for almost one-half of heart failure (HF) cases, thus presenting a major challenge in modern cardiology (1) . The prognosis of patients with HF symptoms and sustained systolic function is comparable to patients with reduced systolic function (2) . Despite extensive research, all efforts to develop successful treatment strategies have led to unsatisfactory results (3) (4) (5) (6) . The lack of consistent therapeutic success might partly be explained by the heterogeneous cohort of patients investigated in previous studies, who exhibit exercise intolerance elicited by different pathophysiological mechanisms (7) (8) (9) (10) (11) . Thus, there is a need to optimize patient characterization to enable scientists and clinicians to successfully tailor individual treatments.
Diastolic dysfunction can frequently be diagnosed in HFpEF patients and is associated with an impairment of active left ventricular (LV) relaxation and/or LV compliance, which in turn results in a disproportional rise in LV filling pressures during exercise (7, 12) .
Diffuse myocardial fibrosis and an increase in extracellular matrix have been suggested as potential mechanisms for increased LV stiffness and diastolic dysfunction (13) (14) (15) .
Cardiac magnetic resonance (CMR) imaging is a noninvasive tool that allows reliable characterization of myocardial tissue. With the recent advent of T 1 mapping techniques, it has become possible to quantify diffuse changes to the extracellular space. Postcontrast T 1 times and extracellular volume fraction (ECV) correlate with histological collagen volume fraction in vivo and in vitro (16, 17) .
The diagnostic value of T 1 mapping techniques in patients with HFpEF needs to be further determined.
Invasive tracings of pressure-volume (PV) relations represent the gold standard for assessing left ventricular (LV) load-independent mechanical diastolic properties. Moreover, this technique provides the opportunity to instantly assess different aspects of diastolic function and the end-diastolic pressurevolume relation (EDPVR) under altering loading conditions (18, 19) .
This study examined the relationship between ECV and invasively measured parameters of diastolic function, and also investigated the potential of ECV to differentiate between different pathomechanisms in HFpEF.
METHODS
This was a prospective study conducted at the Heart Center, Leipzig University, Germany. Patients with clinical and echocardiographic evidence for HFpEF were included, and patients without HF symptoms but indication for invasive coronary angiography served as control subjects. HFpEF patients were identified according to a consensus paper of the European Society of Cardiology (20) , using specific inclusion criteria: left ventricular ejection fraction (LVEF) $50%; New York Heart Association functional class $II; and E/E 0 (explanation in next section) 15 Roche, Basel, Switzerland). Assay-specific elevations >220 pg/ml were considered relevant.
To ensure comparable levels of intravascular volumes, CMR imaging and cardiac catheterization were preceded by an intravenous infusion of 500 ml saline solution. To reduce significant confounding, oral medication was withheld on the day of diagnostic workup.
The study was approved by the local ethics committee, and all patients gave written informed consent. Patients were encouraged to exercise until exhaustion.
CMR was performed immediately before invasive catheterization. All scans were performed on an Intera 1.5-T scanner (Koninklijke Philips N.V., Amsterdam, the Netherlands).
The CMR protocol consisted of cine-sequences, T 1 -weighted spin-echo, and 2-dimensional inversion recovery gradient echo sequences for late enhancement assessment after gadobutrol administration. To increase afterload, patients were asked to perform handgrip exercise for 1 min, and PV data were acquired at baseline and throughout peak exercise.
The time constant of active relaxation, or tau, was calculated after the method of Mirsky (25) In a first step, comparisons were made between patients with HFpEF and control subjects. In a second Values are mean AE SD, n (%), or median (interquartile range).
ACEI ¼ angiotensin-converting enzyme inhibitor; AF ¼ atrial fibrillation; ARB ¼ angiotensin receptor blocker; BMI ¼ body mass index; BP ¼ blood pressure; COPD ¼ chronic obstructive pulmonary disease; eGFR ¼ estimated glomerular filtration rate; HFpEF ¼ heart failure with preserved ejection fraction; hs-CRP ¼ high sensitivity C-reactive protein; NT-proBNP ¼ N-terminal pro-B-type natriuretic peptide; NYHA ¼ New York Heart Association; OSA ¼ obstructive sleep apnea.
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RESULTS
During the study period, 45 patients were considered suitable after echocardiographic assessment. Of these, 2 patients were excluded due to incomplete CMR studies, another 5 excluded due to significant CAD, and 2 due to atrial fibrillation during catheterization.
Therefore, 12 patients served as control subjects and 24 patients with HFpEF were included for final analyses.
HFpEF patients were older, were more frequently female, had a higher body mass index, were more likely to have hypertension, and had a numerically higher rate of paroxysmal atrial fibrillation ( Table 1 ). All patients in the final analysis had complete data for CMR and echocardiographic examinations; patients with HFpEF had bigger left atrial volumes, higher E/E 0 ratios, and longer Ar-A durations ( Table 2) .
Late gadolinium enhancement (LGE) was observed 
CORRELATION OF MEASURES OF DIASTOLIC FUNCTION.
Markers of intrinsic systolic performance (contractility as defined by Ees) and arterial elastance (Ea) were comparable between groups. HFpEF patients had higher LV EDPs at baseline and during exercise as well as a more pronounced increase in EDPVR in response to physical exertion (DEDPVR) ( Table 3) Rommel et al. Both groups had a pathological increase in EDPVR during exercise compared with control subjects with no between-group difference ( Figure 2 , Table 4 ).
Although the group with ECV below the median showed a significantly higher beta, a lower-thanmedian ECV identified patients with a higher Ea, a hypertensive reaction to physical exercise with markedly elevated filling pressures, and prolonged active relaxation (Figures 2 and 3 , Table 4 ).
REPRODUCIBILITY OF PV-LOOP MEASUREMENTS.
Bland-Altman analysis demonstrated acceptable agreement with the following average differences be- LLA: À7.0 ms) (Online Figure 1) . The reproducibility coefficients (given as percent of the average value of the measurements) were: 13% for ESPVR; 34% for EDPVR; 14% for Ees; 28% for Ea; 17% for tau; and 30% for beta. There was no significant proportional bias. ECV assessment allowed for classification of HFpEF Table 2 . The invasive recording of PV relations is the only way to directly assess the heart's diastolic properties.
Therefore, the stiffness constant beta is related to a decreased ventricular compliance, consistent with intrinsic myocardial stiffening (12) . Tau, or time Values are mean AE SD or median (interquartile range). Tables 2 and 3 .
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T 1 Mapping for Quantification of LV Stiffness Use of cardiac magnetic resonance T 1 mapping to quantify myocardial fibrosis as ECV independently predicted LV stiffness in patients with
HFpEF, whereas degree of ECV helped distinguish among pathomechanisms in HFpEF. ECV ¼ extracellular volume fraction; HF ¼ heart failure;
HFpEF ¼ heart failure with preserved ejection fraction; LV ¼ left ventricle. 
